{"id":"W2990546292","doi":"10.23736/s1121-421x.19.02625-4","title":"Therapeutic drug monitoring with vedolizumab in inflammatory bowel disease","year":2020,"lang":"en","type":"review","venue":"Minerva Gastroenterologica e Dietologica","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Vedolizumab; Medicine; Therapeutic drug monitoring; Inflammatory bowel disease; Intensive care medicine; Drug; Clinical trial; Clinical Practice; Disease; Internal medicine; Pharmacology; Physical therapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"low","status":"direct model label, unvalidated"},{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"high","status":"direct model label, unvalidated"}],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000411025,0.001150594,0.002863145,0.0002506693,0.0001529882,0.00006270995,0.001135947,0.000742094,0.0003066575],"category_scores_gemma":[0.0001646629,0.0006645193,0.0007624938,0.0003552593,0.0006814459,0.00008231906,0.0004672643,0.001785668,0.0001903046],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000164354,"about_ca_system_score_gemma":0.0001241934,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00000681239,"about_ca_topic_score_gemma":0.000008953145,"domain_scores_codex":[0.994506,0.001606423,0.001141534,0.001364071,0.0001218291,0.001260135],"domain_scores_gemma":[0.9980519,0.0003816382,0.0005781264,0.0007240626,0.00006026446,0.0002039632],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002735017,0.001101167,0.07171921,0.006813715,0.001735052,0.002788137,0.0001258694,0.000005047749,0.00008516987,0.0001464401,0.001735396,0.9110098],"study_design_scores_gemma":[0.001366956,0.001240971,0.01642618,0.005413284,0.001450479,0.000233954,0.00007775578,0.00000451909,0.000009420068,0.00007158336,0.9729182,0.0007866746],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001496873,0.9956563,0.00003941711,0.0007708758,0.0004539049,0.0010375,0.0001046708,0.0002198306,0.0002206063],"genre_scores_gemma":[0.009138976,0.9886267,0.0006290907,0.000444786,0.0001366551,0.0004216062,0.0001032914,0.00007377969,0.000425111],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9711828,"threshold_uncertainty_score":0.9995806,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04394553222243223,"score_gpt":0.3034427132446421,"score_spread":0.2594971810222099,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}